Capricor Therapeutics (CAPR) Other financing activities (2013 - 2024)

Capricor Therapeutics' Other financing activities history runs 9 years deep, the most recent figure standing at $2.3 million for Q4 2024.

• In Q4 2024, Other financing activities rose 23.31% year-over-year to $2.3 million; the TTM figure through Dec 2024 stood at $9.8 million (up 32.1% YoY), while the FY2024 annual figure was $9.8 million, up 32.1% from the prior year.
• Other financing activities was $2.3 million for Q4 2024 at Capricor Therapeutics, up from $2.1 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $3.3 million in Q1 2024 to a low of $287807.0 in Q1 2020.
• Historically, Other financing activities has averaged $1.3 million across 5 years, with a median of $1.1 million in 2022.
• The sharpest annual moves came in 2020 and 2021: Other financing activities soared 467.03% in 2020, then grew 1.13% in 2021.
• A 5-year view of Other financing activities shows it stood at $473745.0 in 2020, then soared by 64.68% to $780150.0 in 2021, then soared by 47.18% to $1.1 million in 2022, then jumped by 62.14% to $1.9 million in 2023, then rose by 23.31% to $2.3 million in 2024.
• The last three Other financing activities figures came in at $2.3 million (Q4 2024), $2.1 million (Q3 2024), and $2.2 million (Q2 2024), per Business Quant data.